The Structural Asymmetry of Mitochondrial Hsp90 (Trap1) Determines Fine Tuning of Functional Dynamics

被引:51
|
作者
Moroni, Elisabetta [1 ]
Agard, David A. [2 ,3 ]
Colombo, Giorgio [4 ,5 ]
机构
[1] IRCCS Multimed, Via Fantoli 16-15, I-20138 Milan, Italy
[2] Univ Calif San Francisco, Howard Hughes Med Inst, 600 16th St, San Francisco, CA 94158 USA
[3] Univ Calif San Francisco, Dept Biochem & Biophys, 600 16th St, San Francisco, CA 94158 USA
[4] CNR, Ist Chim Riconoscimento Mol, Via Mario Bianco 9, I-20131 Milan, Italy
[5] Univ Pavia, Dipartimento Chim, Vle Taramelli 12, I-27100 Pavia, Italy
关键词
MOLECULAR CHAPERONE HSP90; CONFORMATIONAL DYNAMICS; ESCHERICHIA-COLI; DRUG DISCOVERY; PROTEINS; INHIBITORS; ALLOSTERY; LIGANDS; MOTION; SIMULATIONS;
D O I
10.1021/acs.jctc.7b00766
中图分类号
O64 [物理化学(理论化学)、化学物理学];
学科分类号
070304 ; 081704 ;
摘要
The Hsp90 family of molecular chaperones oversees the folding of a wide range of client proteins. Hsp90 is a homodimer, whose conformational states and functions are regulated by ATP-binding and hydrolysis. The crystal structure of mitochondrial Hsp90 (Trap1) showed that one of the two protomers in the active state is buckled, resulting in an asymmetric conformation. The asymmetry between the two protomers corresponds to the broadly conserved region responsible for client binding. Moreover, asymmetry determines differential hydrolysis for each protomer, with the buckled conformation favoring ATP processing. Experimental results show that after the first hydrolysis the dimer flips to a different asymmetric state while remaining in a closed conformation for the second hydrolysis. In this model, asymmetry plays a key role in the mechanism that drives chaperone function. Herein, we investigate the nucleotide-dependent internal dynamics of Trap1 with computational approaches. Our results shed light on the relationship between the nucleotide state in the N-terminal domain and the asymmetric modulation of the dynamic and structural properties of the client-binding region in the Middle domain. According to our analysis, this is the region that undergoes the most intense dynamic modulation upon nucleotide exchange. This result provides molecular insights into the roles of structural asymmetry in the regulation of Trap1 and suggests that this substructure is a promising target to modulate the functionally oriented aspects of Trap] dynamics, therefore opening fresh opportunities for the design of selective therapeutics for Trap1-dependent diseases.
引用
收藏
页码:1033 / 1044
页数:12
相关论文
共 50 条
  • [1] The ATPase cycle of the mitochondrial Hsp90 analog trap1
    Leskovar, Adriane
    Wegele, Harald
    Werbeck, Nicolas D.
    Buchner, Johannes
    Reinstein, Jochen
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2008, 283 (17) : 11677 - 11688
  • [2] The Mitochondrial HSP90 Paralog TRAP1: Structural Dynamics, Interactome, Role in Metabolic Regulation, and Inhibitors
    Joshi, Abhinav
    Ito, Takeshi
    Picard, Didier
    Neckers, Len
    BIOMOLECULES, 2022, 12 (07)
  • [3] The Mitochondrial Hsp90 TRAP1 and Alzheimer's Disease
    Dekker, Francoise A.
    Rudiger, Stefan G. D.
    FRONTIERS IN MOLECULAR BIOSCIENCES, 2021, 8
  • [4] Structural Asymmetry in the Closed State of Mitochondrial Hsp90 (TRAP1) Supports a Two-Step ATP Hydrolysis Mechanism
    Lavery, Laura A.
    Partridge, James R.
    Ramelot, Theresa A.
    Elnatan, Daniel
    Kennedy, Michael A.
    Agard, David A.
    MOLECULAR CELL, 2014, 53 (02) : 330 - 343
  • [5] The role of TRAP1, the mitochondrial Hsp90 in cancer progression and as a possible therapeutic target
    Sarkar, Sena
    Halder, Babli
    CURRENT SCIENCE, 2023, 124 (06): : 671 - 685
  • [6] TRAP-1, the mitochondrial Hsp90
    Altieri, Dario C.
    Stein, Gary S.
    Lian, Jane B.
    Languino, Lucia R.
    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH, 2012, 1823 (03): : 767 - 773
  • [7] The Role of HSP90 and TRAP1 Targets on Treatment in Hepatocellular Carcinoma
    Kumar, P. K. Praveen
    Sundar, Harini
    Balakrishnan, Kamalavarshini
    Subramaniam, Sakthivel
    Ramachandran, Hemalatha
    Kevin, M.
    Gromiha, M. Michael
    MOLECULAR BIOTECHNOLOGY, 2024, : 1367 - 1381
  • [8] Cytosolic Hsp90α and its mitochondrial isoform Trap1 are differentially required in a breast cancer model
    Vartholomaiou, Evangelia
    Madon-Simon, Marta
    Hagmann, Stephane
    Muehlebach, Guillaume
    Wurst, Wolfgang
    Floss, Thomas
    Picard, Didier
    ONCOTARGET, 2017, 8 (11) : 17428 - 17442
  • [9] New TRAP1 and Hsp90 chaperone inhibitors with cationic components: Preliminary studies on mitochondrial targeting
    Rondanin, R.
    Lettini, G.
    Oliva, P.
    Baruchello, R.
    Costantini, C.
    Trapella, C.
    Simoni, D.
    Bernardi, T.
    Sisinni, L.
    Pietrafesa, M.
    Ponterini, G.
    Costi, M. P.
    Vignudelli, T.
    Luciani, R.
    Matassa, D. S.
    Esposito, F.
    Landriscina, M.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2018, 28 (13) : 2289 - 2293
  • [10] The mitochondrial HSP90 paralog TRAP1 forms an OXPHOS-regulated tetramer and is involved in mitochondrial metabolic homeostasis
    Joshi, Abhinav
    Dai, Li
    Liu, Yanxin
    Lee, Jungsoon
    Ghahhari, Nastaran Mohammadi
    Segala, Gregory
    Beebe, Kristin
    Jenkins, Lisa M.
    Lyons, Gaelyn C.
    Bernasconi, Lilia
    Tsai, Francis T. F.
    Agard, David A.
    Neckers, Len
    Picard, Didier
    BMC BIOLOGY, 2020, 18 (01)